about
Antimalarial activities of peptide antibiotics isolated from fungiData mining of the transcriptome of Plasmodium falciparum: the pentose phosphate pathway and ancillary processes.Transition-state inhibitors of purine salvage and other prospective enzyme targets in malariaThe plasma membrane permease PfNT1 is essential for purine salvage in the human malaria parasite Plasmodium falciparumBCKDH: the missing link in apicomplexan mitochondrial metabolism is required for full virulence of Toxoplasma gondii and Plasmodium bergheiTargeting purine and pyrimidine metabolism in human apicomplexan parasitesHemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organellePlasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapyHemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic proteaseA pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylationExtensive alterations of blood metabolites in pediatric cerebral malaria.Serum lipids and lipoproteins in malaria--a systematic review and meta-analysisQuaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transportSusceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase.Inward cholesterol gradient of the membrane system in P. falciparum-infected erythrocytes involves a dilution effect from parasite-produced lipids.Metabolic fate of fumarate, a side product of the purine salvage pathway in the intraerythrocytic stages of Plasmodium falciparum.Analysis of flavin oxidation and electron-transfer inhibition in Plasmodium falciparum dihydroorotate dehydrogenase.Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene.Plasmodium serine hydroxymethyltransferase: indispensability and display of distinct localization.Malaria parasite carbonic anhydrase: inhibition of aromatic/heterocyclic sulfonamides and its therapeutic potential.Mitochondrial metabolism of sexual and asexual blood stages of the malaria parasite Plasmodium falciparum.In vitro alterations do not reflect a requirement for host cell cycle progression during Plasmodium liver stage infection.Variant surface antigens of malaria parasites: functional and evolutionary insights from comparative gene family classification and analysis.Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase gene from Trypanosoma brucei.Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitorComparative complement selection in bacteria enables screening for lead compounds targeted to a purine salvage enzyme of parasitesKinetics of Plasmodium falciparum thymidylate synthase: interactions with high-affinity metabolites of 5-fluoroorotate and D1694Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities.PG12, a phospholipid analog with potent antimalarial activity, inhibits Plasmodium falciparum CTP:phosphocholine cytidylyltransferase activity.Antimalarial activity of a combination of 5-fluoroorotate and uridine in miceIn vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolismA malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei.Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2.The avian malaria Plasmodium lophurae has a small number of heterogeneous ribosomal RNA genes.Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum.Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum.Evolutionary context for the association of γ-globin, serum uric acid, and hypertension in African Americans.
P2860
Q24550621-42085C0F-AF5B-4FF0-873F-9523AD198650Q24791861-E31FE454-8362-458E-9356-A03EE2625AA7Q27014881-FE618858-15F8-4E78-B22F-D732AB80A793Q27973844-533FD56C-D9FC-412A-ACDD-E43F57996D64Q28540877-CC702D05-B46F-4448-B62B-684D28BD1C31Q28629739-E6921B15-D893-4486-B339-6AB85B6DA936Q28972254-FF552EA2-D660-4A17-AB01-76DCD86CCC0FQ30044494-D8467AF1-2F93-45B4-8159-19D5605F73A0Q30045945-FAAD7F62-07E6-4F78-BAAD-D2225C340D8DQ30046703-C5BB3257-ADB2-4AC6-934E-9D13182A5EEFQ33584763-279F1DF3-1D91-4D7B-BA6D-02B1B1AAF996Q33642820-37244C61-7035-4CB3-B6C0-BED8FF23EFAEQ33738906-67DC189A-4FF1-4154-95D7-994BD12DBA29Q33750695-56B42FD1-B179-4050-92BD-FEE9A81A41E4Q33757276-AD4D84A3-975E-4874-8AEB-3E08B39F83ECQ33786498-DEB99124-5F03-4DEF-B05C-4693B7F83BB2Q33844680-A3B60EB2-43EA-4E0D-9045-696226E0CF37Q33935408-3B29FC5D-586E-4C2A-9884-23D8FCEBEBCFQ34207289-FFBFD36F-C0A0-4F60-A077-DB7D5024869FQ34370204-51FE7E03-6A4F-44F3-AB43-098B1F05DE37Q34485691-C911A445-C07D-4372-9A48-7BA3A3057B6DQ34660349-69006221-E828-4E5E-9427-763B0D937B2DQ34771510-76EF2F38-D76B-4A5B-8E23-00F61762CC41Q34785281-8BA18151-A49B-4D5F-8E21-DA10C129C052Q34785832-2F6989C2-6D5D-4512-AEAD-59AE6E88626BQ35018942-C24662BE-9A20-4E32-B85B-146B8DA2CA0BQ35091549-EDC582DE-9C46-4E7B-9E54-4BD67044BA89Q35112196-91973ADA-C2F8-40C1-8504-787E58E97208Q35125528-59A85E00-EB36-4536-B71B-C04BF3C504F1Q35166107-F290A9D8-083B-49F0-BBD0-515D38C6314EQ35309698-794AE0A0-8F5B-46E2-A167-0E82E8AE2215Q35565199-19A6FBDE-0335-473F-9A6B-0B1465EC4CBCQ35565282-545F37DD-4774-4BDD-8DA7-9A270E50168DQ35592776-8F33FE61-8B35-4C2A-8522-E7200BC58398Q35599510-010D75B3-A469-45D3-BBDC-1D958310A46DQ35607939-1115DA18-8563-4230-8A46-68A1FBF3B7AFQ35694148-74813904-F240-4393-AD95-098E7EE912A4Q35823321-5DBC34F6-F9A4-48FB-A18E-A4040AB2FF0BQ35845458-27E94A6B-0E2E-485C-96EA-A21A43E3F16DQ35873557-9F67E059-46F4-44B5-B5AF-F3997D39E8C5
P2860
description
1979 nî lūn-bûn
@nan
1979 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Biochemistry of Plasmodium (malarial parasites).
@ast
Biochemistry of Plasmodium (malarial parasites).
@en
type
label
Biochemistry of Plasmodium (malarial parasites).
@ast
Biochemistry of Plasmodium (malarial parasites).
@en
prefLabel
Biochemistry of Plasmodium (malarial parasites).
@ast
Biochemistry of Plasmodium (malarial parasites).
@en
P2860
P1476
Biochemistry of Plasmodium (malarial parasites).
@en
P2093
Sherman IW
P2860
P304
P577
1979-12-01T00:00:00Z